EBRO 2017

Case 4 Management

• Most likely to be grade 2 astrocytoma • Bx would help • Prognosis in LGG:

Astrocytoma histology Age >=40

Risk Group Score

Median OS

Low risk

7.8 years

0 - 2

Tumor >=6 cm Tumor crossing midline Neurologic deficit

High risk

3.7 years

3 - 5

Prognosis in ‘Low risk’ group: 55 yr old, triple-neg 20mm, 4 LN+ve woman with breast cancer

Pignatti, JCO 2002